Study on Banza's Chickpea Pasta
Claim 1
At Week 12: 90% of participants scored type 3 or type 4 on the Bristol Stool Scale.
Claim 2
At Week 12: Participants experienced a 30% improvement in bloating.
Claim 3
At Week 12: 80% of participants agreed that since eating the chickpea pasta, their gut health had improved.
About
Banza
Banza is on a mission to inspire people to eat more chickpeas and other beans, for their health and the planet’s. Founded in a Detroit kitchen in 2013, Banza reinvented pasta by replacing refined flour with nutrient-dense chickpeas. The result? A better-for-you version of a beloved staple that supports gut health, boosts protein intake, and helps people eat more plants, more often.
What is Banza’s Chickpea Pasta?
Banza Chickpea Pasta is a delicious, nutrient-packed alternative to traditional pasta. Made entirely from chickpeas, it offers:
50% more protein
3x the fiber
25% fewer net carbs, compared to average pasta.
With 20g of protein per serving, this gluten-free, plant-based pasta delivers on both taste and nutrition. Available in all your favorite shapes, it makes healthy eating easy and enjoyable, whether you’re cooking for one or feeding the whole family. And because chickpeas are good for the planet, every bowl is a win for sustainability too.
Study Design for
Banza
A 12-week, single-group clinical trial was conducted by Citruslabs to evaluate the effects of Banza Chickpea Pasta on:
Gut health
Blood glucose levels
Overall health and well-being
Participants:
12 individuals aged 21–44 who reported difficulties with gut health and maintaining a healthy diet due to busy lifestyles.
Study Protocol:
Participants consumed Banza Chickpea Pasta once daily, five days a week. Assessments included:
Bristol Stool Scale and GSRS validated questionnaires
Blood and stool sample analysis
Waist circumference tracking
Perception-based wellness questionnaires
Data was collected at Baseline, Week 4, Week 8, and Week 12.
Study Results for
Banza
Gut Health
Bristol Stool Scale improvement:
33.33% of participants had ideal stool consistency (type 3 or 4) at Baseline
This rose to 90.00% by Week 12
Indigestion relief (GSRS score):
Significant improvement by Week 8
39.84% reduction in indigestion subscore (p = 0.0362)
Constipation subscore:
43.37% reduction by Week 12
Perceived Health Benefits
By Week 12, ≥50% of participants agreed with 12 of 13 statements related to product impact, including:
Improved gut health
Reduced bloating
Better weight management
Enhanced overall well-being
Benefits of Clinical Research
In an industry often fueled by unverified claims, clinical validation sets Banza apart. By investing in rigorous, third-party research, the brand ensures that its health benefits are grounded in evidence, not hype. This commitment to transparency reinforces consumer trust and supports the company’s goal of making nutritious food more accessible.
